Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Uncover which credit card gives the best points for your spending habits. Find the right card to maximize your rewards.
19,343 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
A relatively small stock move can reveal big shifts in the lodging REIT world. See why an $8 million sale of Park Hot...
When figma stock popped today, investors watched for catalysts beyond a single headline. This guide breaks down the d...
Kratos Defense stock keeps facing pressure after announcing a sizable stock sale. This guide breaks down dilution, it...
A sudden Medicare policy shift sparked worry for retirees. Lawmakers paused the cut, but only temporarily, leaving yo...
As AI investments surge, can a lagging AI stock reverse course in 2026? This guide breaks down the signals, risks, an...
AI chatbots offer big benefits for learning and managing crypto, but risks exist. This article explains how most chat...
Turn your weekend into a powerful money-move session. This guide offers 10 long-form investing reads and practical st...
Palantir's quarterly results spotlight more than top-line growth. The real signal is how much existing customers are ...
Growth stocks cooled in early 2026, but a trio of ETFs offers a resilient path for long-term investors. This piece br...
As the world leans harder on reliable, low-emission power, these nuclear energy stocks could offer compelling opportu...
Tech shares wobble as regulatory headlines hit the tape. This piece breaks down the Snap slump, regulatory risks from...